A. H. Miners, G. Yao, J. Raftery and R. S. Taylor, “Economic Evaluations of Calcineurin Inhibitors in Renal Transplantation: A Literature Review,” Pharmacoeconomics, Vol. 25, No. 11, 2007, pp. 935-947.
 R. L. Morton, K. Howard, A. C. Webster, G. Wong and J. C. Craig, “The Cost-Effectiveness of Induction Immunosuppression in Kidney Transplantation,” Nephrology Dialysis Transplantation, Vol. 24, No. 7, 2009, pp. 2258-2269. http://dx.doi.org/10.1093/ndt/gfp174
 S. D. Sullivan, L. P. Garrison Jr. and J. H. Best, “The Cost Effectiveness of Mycophenolate Mofetil in the First Year after Primary Cadaveric Transplant. U.S. Renal Transplant Mycophenolate Mofetil Study Group,” Journal of the American Society of Nephrology, Vol. 8, No. 10, 1997, pp. 1592-1598.
 D. Chaib-Eddour, H. Chaib-Eddour, J. Malaise, et al., “Cost of Renal Transplant in Belgium,” Transplantation Proceedings, Vol. 37, No. 6, 2005, pp. 2819-2820.
 M. A. Gentil, F. González-Roncero, C. Cantarell, et al., “Effect of New Immunosuppressive Regimens on Cost of Renal Transplant Maintenance Immunosuppression,” Transplantation Proceedings, Vol. 37, No. 3, 2005, pp. 1441-1442. http://dx.doi.org/10.1016/j.transproceed.2005.02.012
 E. K. L. Lee and P. L. Tseng, “Retrospective Study on the Utilization and Cost of Immunosuppressive Agents among Kidney Transplant Recipients in Taiwan: A 5-Year Review,” Transplantation Proceedings, Vol. 40, No. 7, 2008, pp. 2214-2271.
 E. K. L. Lee, T. M. Cham and P. L. Tseng, “A Retrospective Study on the Utilization of and Expenditure for Immunosuppressants for Organ Transplant Recipients in Taiwan—Updated to 2006,” Transplantation Proceedings, Vol. 42, No. 3, 2010, pp. 961-965.
 E. F. Yena, K. Hardinger, D. C. Brennan, et al., “CostEffectiveness of Extending Medicare Coverage of Immunosuppressive Medications to the Life of a Kidney Transplant,” American Journal of Transplantation, Vol. 4, No. 10, 2004, pp. 1703-1708.
 Ministry of Health, “Regulation 34 for the Order of Payment from the Governmental Budget the Therapy of the Bulgarian Citizens That Is Not Covered by the Obligatory Health Insurance,” Governmental Newspaper, Vol. 95, 2005.
 S. K. Takemoto, B. W. Pinsky, M. A. Schnitzler, et al., “A Retrospective Analysis of Immunosupression Compliance, Dose Reduction and discontinuation in Kidney Transplant Patient,” American Journal of Transplantation, Vol. 7, No. 12, 2007, pp. 2704-2711.
 E. Nemati, A. R. Saadat, M. Hashemi, et al., “Causes of Rehospitalization after Renal Transplantation; Does Age of Recipient Matter?” Transplantation Proceedings, Vol. 39, No. 4, 2007, pp. 970-973.